Results 21 to 30 of about 7,596 (176)

A successful outcome of pregnancy in a patient with congenital antithrombin deficiency [PDF]

Vojnosanitetski Pregled, 2011
Background. Presence of inherited thrombophilia is an additional risk factor for maternal thromboembolism and certain adverse pregnancy outcomes, including recurrent fetal loss, placental abruption, intrauterine growth restriction and earlyonset severe ...
Kovač Mirjana, Miković Željko, Rakičević Ljiljana, Srzentić Snežana, Mandić Vesna, Đorđević Valentina, Radojković Dragica   +6 more
doaj   +1 more source

Antithrombin III in the prevention of thrombotic complications in high risk patients undergoing liver transplantation

Трансплантология (Москва), 2019
Introduction. Recent studies have indicated an increased incidence of thrombotic vascular complications after liver transplantation. The reasons may be associated with surgical technique and “unbalanced” hemostasis in patients with diffuse liver diseases.
N. K. Kuznetsova, E. V. Klychnikova, S. V. Zhuravel, O. D. Olisov, I. I. Utkina, M. S. Novruzbekov, V. I. Reshetnyak   +6 more
doaj   +1 more source

Overcoming heparin resistance in pregnant women with antithrombin deficiency: a case report and review of the literature

Journal of Medical Case Reports, 2018
Background The risk of thromboembolic events during pregnancy in patients with antithrombin deficiency is increased. Preventing thromboembolic events during pregnancy in the case of antithrombin deficiency is still a matter of concern.
Panagiotis Tsikouras, Anna Christoforidou, Anastasia Bothou, Dorelia Deuteraiou, Xanthoula Anthoulaki, Anna Chalkidou, Stefanos Zervoudis, Georgios Galazios   +7 more
doaj   +1 more source

Pulmonary Artery Endarterectomy with Deep Hypothermic Circulatory Arrest in a Patient with a Congenital Antithrombin III Deficiency. [PDF]

Ann Card Anaesth
Diop S, Fadel E, Kassab MC, Genty T, Ion I.   +4 more
europepmc   +2 more sources

Supplementation therapy with Antithrombin Drugs in the Combined Treatment of Sepsis

Общая реаниматология, 2019
Purpose — to assess the efficacy of supplementation therapy for antithrombin deficiency in the combined treatment of sepsis.Materials and methods. A prospective-retrospective study of the efficacy of supplementation therapy for antithrombin deficiency ...
I. V. Redkin, A. F. Lopatin, A. G. Yavorovskiy, V. V. Likhvantsev   +3 more
doaj   +1 more source

A COVID-19 case report with low ACT(activated clotting time) and high serum D-dimer level: Antithrombin III deficiency? [PDF]

Respirol Case Rep
The Coronavirus Disease 2019 (COVID‐19), caused by the virus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), is a global public health problem in which atypical findings other than the usual fever and respiratory symptoms render early
Şahin Tutak A.
europepmc   +2 more sources

Correction of Antithrombin III Deficiency in Disseminated Intravascular Coagulation

Общая реаниматология, 2008
Although antithrombin (AT) III concentrate therapy is attended by an increased risk of hemorrhage, the data available in the literature suggest that the agent may have a positive effect on outcome in disseminated intravascular coagulation (DIC ...
Ye. L. Neporada, N. A. Vorobyeva, E. V. Nedashkovsky   +2 more
doaj   +1 more source

Prevalence of thrombophilia in indian patients with deep venous thrombosis – An 8-year single-center study

Indian Journal of Vascular and Endovascular Surgery, 2022
Background: Thrombophilia is a recognized risk factor for deep venous thrombosis (DVT) and its recurrence. Routine thrombophilia testing is controversial because of low yield and high cost.
Vivek Agrawal, Sanjeev Kumar Deshpande, Brijesh Biswas, Suresh Reddy Thupakula, Vembu Anand   +4 more
doaj   +1 more source

Hereditary Antithrombin Deficiency in Pediatric Patients: Pathophysiology, Clinical Features, Diagnosis, and Antithrombin Replacement Therapy. [PDF]

Clin Appl Thromb Hemost
Antithrombin (AT), a glycoprotein, plays a key role in anticoagulation by inhibiting coagulation proteases. It is also the primary mediator of heparin's anticoagulant effect, with heparin binding amplifying AT activity up to 1000-fold.
Rodgers GM, Rodriguez WI.
europepmc   +2 more sources

Frequency of Protein C, S and Antithrombin III Deficiency and Presence of Antibodies of Antiphospholipid Syndrome in Women with Recurrent Abortion [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2019
Introduction: Recurrent abortion is defined as three or more spontaneous miscarriages before first trimester of pregnancy. Protein C, S, Antithrombin III deficiency is of the min factors of this disease.
Mohammad Matin, Davoud Bashash, Kambiz Hasrak, Ahmadreza Baghestani, Mohsen Hamidpour   +4 more
doaj   +1 more source